Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	myosin V binding	RAB3D RAB3A RAB3B	2.06e-05	20	54	3	GO:0031489
GeneOntologyMolecularFunction	GTP-dependent protein binding	RAB3D RAB3A RAB3B	3.63e-05	24	54	3	GO:0030742
GeneOntologyMolecularFunction	excitatory extracellular ligand-gated monoatomic ion channel activity	HTR3B CHRNA5 CHRNG	2.14e-04	43	54	3	GO:0005231
GeneOntologyMolecularFunction	transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential	HTR3B CHRNA5 CHRNG	4.93e-04	57	54	3	GO:1904315
GeneOntologyMolecularFunction	ligand-gated monoatomic cation channel activity	KCNMB3 HTR3B CHRNA5 CHRNG	5.58e-04	140	54	4	GO:0099094
GeneOntologyMolecularFunction	neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential	HTR3B CHRNA5 CHRNG	5.74e-04	60	54	3	GO:0099529
GeneOntologyMolecularFunction	transmitter-gated channel activity	HTR3B CHRNA5 CHRNG	7.25e-04	65	54	3	GO:0022835
GeneOntologyMolecularFunction	transmitter-gated monoatomic ion channel activity	HTR3B CHRNA5 CHRNG	7.25e-04	65	54	3	GO:0022824
GeneOntologyMolecularFunction	acetylcholine-gated monoatomic cation-selective channel activity	CHRNA5 CHRNG	9.51e-04	17	54	2	GO:0022848
GeneOntologyMolecularFunction	postsynaptic neurotransmitter receptor activity	HTR3B CHRNA5 CHRNG	1.10e-03	75	54	3	GO:0098960
GeneOntologyMolecularFunction	extracellular ligand-gated monoatomic ion channel activity	HTR3B CHRNA5 CHRNG	1.19e-03	77	54	3	GO:0005230
GeneOntologyMolecularFunction	myosin binding	RAB3D RAB3A RAB3B	1.58e-03	85	54	3	GO:0017022
GeneOntologyMolecularFunction	acetylcholine receptor activity	CHRNA5 CHRNG	1.75e-03	23	54	2	GO:0015464
GeneOntologyMolecularFunction	ligand-gated monoatomic ion channel activity	KCNMB3 HTR3B CHRNA5 CHRNG	1.83e-03	193	54	4	GO:0015276
GeneOntologyMolecularFunction	ligand-gated channel activity	KCNMB3 HTR3B CHRNA5 CHRNG	1.98e-03	197	54	4	GO:0022834
GeneOntologyMolecularFunction	scavenger receptor activity	SCARF2 ENDOU	2.41e-03	27	54	2	GO:0005044
GeneOntologyMolecularFunction	neurotransmitter receptor activity	HTR3B CHRNA5 CHRNG	2.51e-03	100	54	3	GO:0030594
GeneOntologyMolecularFunction	polysaccharide binding	CLEC4G ENDOU	3.17e-03	31	54	2	GO:0030247
GeneOntologyMolecularFunction	ATPase activator activity	ATP6AP1 RAB3A	3.38e-03	32	54	2	GO:0001671
GeneOntologyMolecularFunction	DNA-binding transcription activator activity, RNA polymerase II-specific	TFEC MYOD1 FOS MYT1 PROP1 MEOX1	3.91e-03	560	54	6	GO:0001228
GeneOntologyMolecularFunction	DNA-binding transcription activator activity	TFEC MYOD1 FOS MYT1 PROP1 MEOX1	4.12e-03	566	54	6	GO:0001216
GeneOntologyBiologicalProcess	peptidyl-cysteine methylation	RAB3D RAB3B	1.87e-05	3	52	2	GO:0018125
Domain	-	HTR3B CHRNA5 CHRNG	3.67e-05	23	53	3	1.20.120.370
Domain	Acetylcholine_rcpt_TM	HTR3B CHRNA5 CHRNG	3.67e-05	23	53	3	IPR027361
Domain	Neur_chan_memb	HTR3B CHRNA5 CHRNG	3.00e-04	46	53	3	PF02932
Domain	Neur_chan_LBD	HTR3B CHRNA5 CHRNG	3.20e-04	47	53	3	PF02931
Domain	NEUROTR_ION_CHANNEL	HTR3B CHRNA5 CHRNG	3.20e-04	47	53	3	PS00236
Domain	Neurotrans-gated_channel_TM	HTR3B CHRNA5 CHRNG	3.20e-04	47	53	3	IPR006029
Domain	-	HTR3B CHRNA5 CHRNG	3.20e-04	47	53	3	2.70.170.10
Domain	Neur_channel	HTR3B CHRNA5 CHRNG	3.20e-04	47	53	3	IPR006201
Domain	Neur_chan_lig-bd	HTR3B CHRNA5 CHRNG	3.20e-04	47	53	3	IPR006202
Domain	Nicotinic_acetylcholine_rcpt	CHRNA5 CHRNG	9.24e-04	16	53	2	IPR002394
Domain	RAB	RAB3D RAB3A RAB3B	1.17e-03	73	53	3	PS51419
Domain	FYVE	FGD5 ZFYVE1	3.05e-03	29	53	2	PF01363
Domain	FYVE	FGD5 ZFYVE1	3.05e-03	29	53	2	SM00064
Domain	Znf_FYVE-rel	FGD5 ZFYVE1	4.18e-03	34	53	2	IPR017455
Domain	EGF_3	MEGF8 SCARF2 C6 ADAM28	4.42e-03	235	53	4	PS50026
Domain	Laminin_EGF	MEGF8 SCARF2	4.43e-03	35	53	2	PF00053
Domain	EGF_Lam	MEGF8 SCARF2	4.43e-03	35	53	2	SM00180
Domain	Znf_FYVE	FGD5 ZFYVE1	5.20e-03	38	53	2	IPR000306
Domain	Laminin_EGF	MEGF8 SCARF2	5.20e-03	38	53	2	IPR002049
Domain	EGF-like_dom	MEGF8 SCARF2 C6 ADAM28	5.41e-03	249	53	4	IPR000742
Domain	ZF_FYVE	FGD5 ZFYVE1	5.75e-03	40	53	2	PS50178
Domain	EGF_1	MEGF8 SCARF2 C6 ADAM28	5.88e-03	255	53	4	PS00022
Domain	EGF-like_CS	MEGF8 SCARF2 C6 ADAM28	6.38e-03	261	53	4	IPR013032
Domain	EGF_2	MEGF8 SCARF2 C6 ADAM28	6.73e-03	265	53	4	PS01186
Domain	Ras	RAB3D RAB3A RAB3B	6.78e-03	136	53	3	PF00071
Domain	Neurotransmitter_ion_chnl_CS	CHRNA5 CHRNG	7.23e-03	45	53	2	IPR018000
Domain	-	TRIM39 FGD5 ZFYVE1 RNF43 RNF138	8.74e-03	449	53	5	3.30.40.10
Domain	ZF_RING_1	CUL9 TRIM39 RNF43 RNF138	9.29e-03	291	53	4	PS00518
Domain	Znf_RING/FYVE/PHD	TRIM39 FGD5 ZFYVE1 RNF43 RNF138	9.56e-03	459	53	5	IPR013083
Domain	P-loop_NTPase	SAMD9 RAB3D DHX32 ZFYVE1 RAB3A RAB3B ADSS1	9.69e-03	848	53	7	IPR027417
Domain	ZF_RING_2	CUL9 TRIM39 RNF43 RNF138	1.01e-02	298	53	4	PS50089
Domain	Small_GTPase	RAB3D RAB3A RAB3B	1.06e-02	160	53	3	IPR001806
Pubmed	Localization versus function of Rab3 proteins. Evidence for a common regulatory role in controlling fusion.	RAB3D RAB3A RAB3B	1.41e-08	4	54	3	12167638
Pubmed	Rab3 proteins involved in vesicle biogenesis and priming in embryonic mouse chromaffin cells.	RAB3D RAB3A RAB3B	1.41e-08	4	54	3	20716109
Pubmed	A complete genetic analysis of neuronal Rab3 function.	RAB3D RAB3A RAB3B	1.41e-08	4	54	3	15269275
Pubmed	Rab3 superprimes synaptic vesicles for release: implications for short-term synaptic plasticity.	RAB3D RAB3A RAB3B	1.41e-08	4	54	3	16436611
Pubmed	Tctex-1, a novel interaction partner of Rab3D, is required for osteoclastic bone resorption.	RAB3D RAB3A RAB3B	3.53e-08	5	54	3	21262767
Pubmed	Rab3a is involved in transport of synaptic vesicles to the active zone in mouse brain nerve terminals.	RAB3D RAB3A RAB3B	3.53e-08	5	54	3	11598194
Pubmed	Noc2 is essential in normal regulation of exocytosis in endocrine and exocrine cells.	RAB3D RAB3A RAB3B	3.53e-08	5	54	3	15159548
Pubmed	The RAB3-RIM Pathway Is Essential for the Release of Neuromodulators.	RAB3D RAB3A RAB3B	7.05e-08	6	54	3	31679900
Pubmed	Rab3D is not required for exocrine exocytosis but for maintenance of normally sized secretory granules.	RAB3D RAB3A RAB3B	7.05e-08	6	54	3	12192047
Pubmed	Rep15 interacts with several Rab GTPases and has a distinct fold for a Rab effector.	RAB3D RAB3A RAB3B	1.23e-07	7	54	3	35871249
Pubmed	Mono-ubiquitination of Rabphilin 3A by UBE3A serves a non-degradative function.	RAB3D RAB3A RAB3B	1.23e-07	7	54	3	33542309
Pubmed	Identification and characterization of multiple novel Rab-myosin Va interactions.	RAB3D RAB3A RAB3B	1.27e-06	14	54	3	24006491
Pubmed	Detection of bone marrow micrometastasis and microcirculating disease in rhabdomyosarcoma by a real-time RT-PCR assay.	MYOD1 CHRNG	7.09e-06	3	54	2	16435141
Pubmed	Ubiquitylation of p53 by the APC/C inhibitor Trim39.	ANAPC1 TRIM39	7.09e-06	3	54	2	23213260
Pubmed	Long non-coding RNA FGD5-AS1 enhances osteosarcoma cell proliferation and migration by targeting miR-506-3p/RAB3D axis.	RAB3D FGD5	7.09e-06	3	54	2	33891267
Pubmed	Discovery of a Role for Rab3b in Habituation and Cocaine Induced Locomotor Activation in Mice Using Heterogeneous Functional Genomic Analysis.	RAB3D RAB3B	7.09e-06	3	54	2	32742255
Pubmed	SREC-I, a type F scavenger receptor, is an endocytic receptor for calreticulin.	SCARF2 CALR	7.09e-06	3	54	2	15371419
Pubmed	Compartmentalized expression of the alpha- and gamma-subunits of the acetylcholine receptor in recently fused myofibers.	MYOD1 CHRNG	7.09e-06	3	54	2	8482411
Pubmed	Interaction cloning of Rabin3, a novel protein that associates with the Ras-like GTPase Rab3A.	RAB3D RAB3A	7.09e-06	3	54	2	7532276
Pubmed	Distinct functional properties of Rab3A and Rab3B in PC12 neuroendocrine cells.	RAB3A RAB3B	7.09e-06	3	54	2	8636125
Pubmed	Detection and modulation in vivo of helix-loop-helix protein-protein interactions.	MYOD1 FOS	1.42e-05	4	54	2	8380166
Pubmed	GDP/GTP exchange factor MADD drives activation and recruitment of secretory Rab GTPases to Weibel-Palade bodies.	RAB3D RAB3B	1.42e-05	4	54	2	34551092
Pubmed	Rim1 and rabphilin-3 bind Rab3-GTP by composite determinants partially related through N-terminal alpha -helix motifs.	RAB3D RAB3A	1.42e-05	4	54	2	11431472
Pubmed	Isoprenylcysteine carboxyl methyltransferase deficiency in mice.	RAB3D RAB3B	1.42e-05	4	54	2	11121396
Pubmed	Identification of non-cell-autonomous networks from engineered feeder cells that enhance murine hematopoietic stem cell activity.	TFEC FOS	2.36e-05	5	54	2	23340137
Pubmed	The homeodomain protein Barx2 promotes myogenic differentiation and is regulated by myogenic regulatory factors.	MYOD1 FOS	2.36e-05	5	54	2	12486129
Pubmed	A complete Rab screening reveals novel insights in Weibel-Palade body exocytosis.	RAB3D RAB3A	3.54e-05	6	54	2	22899725
Pubmed	Isolation of a cDNA encoding thymic shared antigen-1. A new member of the Ly6 family with a possible role in T cell development.	FOS TG	3.54e-05	6	54	2	8258699
Pubmed	A dual fate of the hindlimb muscle mass: cloacal/perineal musculature develops from leg muscle cells.	MYOD1 MEOX1	3.54e-05	6	54	2	15653949
Pubmed	Dimerization regulates the human APC/C-associated ubiquitin-conjugating enzyme UBE2S.	UBA1 ANAPC1	4.94e-05	7	54	2	33082289
Pubmed	The human Rab genes encode a family of GTP-binding proteins related to yeast YPT1 and SEC4 products involved in secretion.	RAB3A RAB3B	4.94e-05	7	54	2	2501306
Pubmed	Muscle deficiency and neonatal death in mice with a targeted mutation in the myogenin gene.	MYOD1 CHRNG	4.94e-05	7	54	2	8393145
Pubmed	Paradox segmentation along inter- and intrasomitic borderlines is followed by dysmorphology of the axial skeleton in the open brain (opb) mouse mutant.	MYOD1 MEOX1	4.94e-05	7	54	2	9664688
Pubmed	Mox2 is a component of the genetic hierarchy controlling limb muscle development.	MYOD1 MEOX1	4.94e-05	7	54	2	10403250
Pubmed	Nucleotide sequence of a rat cDNA: rab1B, encoding a rab1-YPT related protein.	RAB3A RAB3B	4.94e-05	7	54	2	2493636
Pubmed	Tmem64 modulates calcium signaling during RANKL-mediated osteoclast differentiation.	CALR FOS	6.59e-05	8	54	2	23395171
Pubmed	Aberrant development of motor axons and neuromuscular synapses in MyoD-null mice.	MYOD1 CHRNG	6.59e-05	8	54	2	12832540
Pubmed	Rab18 and a Rab18 GEF complex are required for normal ER structure.	RAB3A RAB3B	8.46e-05	9	54	2	24891604
Pubmed	Genomic organization, chromosomal localization, tissue distribution, and biophysical characterization of a novel mammalian Shaker-related voltage-gated potassium channel, Kv1.7.	FCGRT MYOD1	8.46e-05	9	54	2	9488722
Pubmed	Severe defects in the formation of epaxial musculature in open brain (opb) mutant mouse embryos.	MYOD1 MEOX1	8.46e-05	9	54	2	8565855
Pubmed	RUTBC1 protein, a Rab9A effector that activates GTP hydrolysis by Rab32 and Rab33B proteins.	RAB3A RAB3B	8.46e-05	9	54	2	21808068
Pubmed	Slac2-a/melanophilin, the missing link between Rab27 and myosin Va: implications of a tripartite protein complex for melanosome transport.	RAB3D RAB3A RAB3B	1.03e-04	58	54	3	11856727
Pubmed	Distinct Rab binding specificity of Rim1, Rim2, rabphilin, and Noc2. Identification of a critical determinant of Rab3A/Rab27A recognition by Rim2.	RAB3D RAB3A RAB3B	1.19e-04	61	54	3	12578829
Pubmed	140 mouse brain proteins identified by Ca2+-calmodulin affinity chromatography and tandem mass spectrometry.	NCKAP1 RAB3D RAB3A RAB3B	1.23e-04	163	54	4	16512683
Pubmed	The Slp homology domain of synaptotagmin-like proteins 1-4 and Slac2 functions as a novel Rab27A binding domain.	RAB3D RAB3A RAB3B	1.25e-04	62	54	3	11773082
Pubmed	Structural determinants of Rab and Rab Escort Protein interaction: Rab family motifs define a conserved binding surface.	RAB3A RAB3B	1.29e-04	11	54	2	12535645
Pubmed	Multiple cholinergic nicotinic receptor genes affect nicotine dependence risk in African and European Americans.	CHRNA5 CHRNG	1.55e-04	12	54	2	20584212
Pubmed	A genome-wide RNAi screen identifies multiple synthetic lethal interactions with the Ras oncogene.	UBA1 ANAPC1 CALR TRIM39 C6	1.63e-04	331	54	5	19490893
Pubmed	Screening for target Rabs of TBC (Tre-2/Bub2/Cdc16) domain-containing proteins based on their Rab-binding activity.	RAB3D RAB3A RAB3B	1.96e-04	72	54	3	16923123
Pubmed	Design and expression of human alpha7 nicotinic acetylcholine receptor extracellular domain mutants with enhanced solubility and ligand-binding properties.	CHRNA5 CHRNG	2.13e-04	14	54	2	19059502
Pubmed	Analysis of nicotinic acetylcholine receptor subunits in the cochlea of the mouse.	CHRNA5 CHRNG	2.45e-04	15	54	2	8838678
Pubmed	Lack of the mesodermal homeodomain protein MEOX1 disrupts sclerotome polarity and leads to a remodeling of the cranio-cervical joints of the axial skeleton.	MYOD1 MEOX1	2.45e-04	15	54	2	19520072
Pubmed	Multiple distinct risk loci for nicotine dependence identified by dense coverage of the complete family of nicotinic receptor subunit (CHRN) genes.	CHRNA5 CHRNG	2.80e-04	16	54	2	19259974
Pubmed	Axis specification and morphogenesis in the mouse embryo require Nap1, a regulator of WAVE-mediated actin branching.	NCKAP1 MEOX1	3.17e-04	17	54	2	16831833
Pubmed	Serial backcross mapping of multiple loci associated with resistance to Leishmania major in mice.	IFNGR2 C6	3.17e-04	17	54	2	9175833
Pubmed	A functional screen to identify novel effectors of hematopoietic stem cell activity.	TFEC FOS	3.17e-04	17	54	2	19379700
Pubmed	The murine winged helix transcription factors, Foxc1 and Foxc2, are both required for cardiovascular development and somitogenesis.	MYOD1 MEOX1	3.98e-04	19	54	2	11562355
Pubmed	Identification of transcripts with enriched expression in the developing and adult pancreas.	FOS MYT1 RBP4 RAB3D RNF43 MEOX1	4.05e-04	624	54	6	18554416
Pubmed	TGF-β signaling and Creb5 cooperatively regulate Fgf18 to control pharyngeal muscle development.	MYOD1 MEOX1	4.42e-04	20	54	2	36542062
Pubmed	Disruption of the mouse MRF4 gene identifies multiple waves of myogenesis in the myotome.	MYOD1 CHRNG	4.42e-04	20	54	2	7588068
Pubmed	The effect of neurogenin3 deficiency on pancreatic gene expression in embryonic mice.	MYT1 RBP4	4.88e-04	21	54	2	17032746
Pubmed	Pericentrosomal targeting of Rab6 secretory vesicles by Bicaudal-D-related protein 1 (BICDR-1) regulates neuritogenesis.	RAB3D RAB3A	5.86e-04	23	54	2	20360680
Pubmed	Discovery and fine mapping of serum protein loci through transethnic meta-analysis.	FCGRT CHRNA5	5.86e-04	23	54	2	23022100
Pubmed	Long-term potentiation modulates synaptic phosphorylation networks and reshapes the structure of the postsynaptic interactome.	UBA1 NCKAP1 RAB3A RAB3B	6.31e-04	251	54	4	27507650
Pubmed	A proteomics approach for the identification of cullin-9 (CUL9) related signaling pathways in induced pluripotent stem cell models.	ANAPC1 CUL9	6.39e-04	24	54	2	33705438
Pubmed	Rac1 mediates morphogenetic responses to intercellular signals in the gastrulating mouse embryo.	NCKAP1 MEOX1	6.39e-04	24	54	2	21693517
Pubmed	Distinct transcriptomic changes in E14.5 mouse skeletal muscle lacking RYR1 or Cav1.1 converge at E18.5.	MYOD1 FOS	9.35e-04	29	54	2	29543863
Pubmed	Large-scale proteomics and phosphoproteomics of urinary exosomes.	UBA1 ATP6AP1 MEGF8 NCKAP1 RBP4 RAB3D RAB3B	9.52e-04	1016	54	7	19056867
Pubmed	Recapitulating early development of mouse musculoskeletal precursors of the paraxial mesoderm in vitro.	MYOD1 MEOX1	1.00e-03	30	54	2	29555813
Pubmed	Genome-wide mapping of Sox6 binding sites in skeletal muscle reveals both direct and indirect regulation of muscle terminal differentiation by Sox6.	MYOD1 CHRNG	1.07e-03	31	54	2	21985497
Pubmed	Target gene selectivity of the myogenic basic helix-loop-helix transcription factor myogenin in embryonic muscle.	MYOD1 ADSS1	1.14e-03	32	54	2	17904117
Pubmed	Analysis of mouse embryonic patterning and morphogenesis by forward genetics.	NCKAP1 MEOX1	1.21e-03	33	54	2	15755804
Pubmed	EZH2 interacts with HP1BP3 to epigenetically activate WNT7B that promotes temozolomide resistance in glioblastoma.	UBA1 SAMD9 ATP6AP1 NCKAP1 CALR TG	1.50e-03	803	54	6	36517590
Pubmed	Effects of glucokinase haploinsufficiency on the pancreatic β-cell mass and function of long-term high-fat, high-sucrose diet-fed mice.	FOS RBP4	1.52e-03	37	54	2	39305123
Pubmed	Impact of cytosine methylation on DNA binding specificities of human transcription factors.	TFEC MYOD1 FOS PROP1 MEOX1	1.55e-03	544	54	5	28473536
Interaction	REP15 interactions	RAB3D RAB3A RAB3B	1.97e-05	21	51	3	int:REP15
Interaction	VRTN interactions	RAB3D RAB3A RAB3B	1.97e-05	21	51	3	int:VRTN
Interaction	RIMS2 interactions	RAB3D RAB3A RAB3B	4.28e-05	27	51	3	int:RIMS2
Cytoband	18q12.1	TRAPPC8 RNF138	4.33e-04	26	54	2	18q12.1
GeneFamily	RAB, member RAS oncogene GTPases	RAB3D RAB3A RAB3B	4.94e-04	65	43	3	388
GeneFamily	Cholinergic receptors nicotinic subunits	CHRNA5 CHRNG	6.49e-04	16	43	2	173
GeneFamily	Zinc fingers FYVE-type\|Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors	FGD5 ZFYVE1	2.46e-03	31	43	2	81
ToppCell	3'-GW_trimst-1.5-SmallIntestine-Epithelial-neuro-epithelial-EECs\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CFAP47 CLEC20A CUL9 RAB3B SDK1 RNF43	8.71e-08	185	53	6	d42f6722a6771752cd744146a09e2ead9b7252bc
ToppCell	BAL-Mild-Myeloid-MoAM-MoAM3-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	IFNGR2 TFEC FCGRT FOS RAB3D	3.35e-06	193	53	5	93ba635ed69fec9286fe7636b9d258f3d93a22c3
ToppCell	BAL-Mild-Myeloid-MoAM-MoAM3\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	IFNGR2 TFEC FCGRT FOS RAB3D	3.35e-06	193	53	5	6dfdeb793cb5ad6412b6f808b5687a4e74b6ec65
ToppCell	BAL-Mild-Myeloid-MoAM-MoAM3-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	IFNGR2 TFEC FCGRT FOS RAB3D	3.43e-06	194	53	5	e455cb469157c044126f9b0b308957d4ee1e608b
ToppCell	BAL-Mild-Myeloid-MoAM-MoAM3\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	IFNGR2 TFEC FCGRT FOS RAB3D	3.43e-06	194	53	5	e0cfd18a7ea2251163d61312b9397f8a518c8c51
ToppCell	Mild_COVID-19-Myeloid-MoAM3\|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30）	IFNGR2 TFEC FCGRT FOS RAB3D	3.61e-06	196	53	5	9faad17aa0b6af5a8ec2dadf7d70b9209d658072
ToppCell	(000)_CD14+_Monocyte\|World / immune cells in Peripheral Blood (logTPM normalization)	IFNGR2 TFEC FCGRT FOS RAB3D	3.70e-06	197	53	5	cff498bc7b153f28dd013eaeb73ead4fb62fb44c
ToppCell	PBMC-Convalescent-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_2\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	IFNGR2 TFEC FCGRT FOS RAB3D	3.70e-06	197	53	5	6e96a6c2576f52b72aeab1e41f47a0af05ff327a
ToppCell	PBMC-Convalescent-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_2\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	IFNGR2 TFEC FCGRT FOS RAB3D	3.70e-06	197	53	5	a80be1081f3ed0aceea69a33be21bca6bc354472
ToppCell	COVID-19_Convalescent-Myeloid-Classical_Monocyte\|COVID-19_Convalescent / Disease group, lineage and cell class	IFNGR2 TFEC FCGRT FOS RAB3D	3.79e-06	198	53	5	ca58c62d7f732631af1f7cabaa785757d031c011
ToppCell	Control_saline-Endothelial-Endothelial-Activated_Gen_Cap\|Control_saline / Treatment groups by lineage, cell group, cell type	SAMD9 MEIOC FOS C6 MEOX1	3.79e-06	198	53	5	3c3a5d2555f6af4aa33f9ea778808315d0e39d86
ToppCell	PBMC-Convalescent-Myeloid-Classical_Monocyte\|Convalescent / Location, Disease Group, Cell group, Cell class (2021.03.09)	IFNGR2 TFEC FCGRT FOS RAB3D	3.79e-06	198	53	5	708f9644362d300ecc477d76208e4957bb92487e
ToppCell	PBMC-Convalescent-Myeloid-Classical_Monocyte\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	IFNGR2 TFEC FCGRT FOS RAB3D	3.79e-06	198	53	5	e2ead6886548638f94e9302b8eb8d797ce454d41
ToppCell	PBMC-Convalescent-Myeloid-Classical_Monocyte-Classical_Monocyte\|Convalescent / Location, Disease Group, Cell group, Cell class (2021.03.09)	IFNGR2 TFEC FCGRT FOS RAB3D	3.79e-06	198	53	5	711618d47281c07e89723482c28570449eb7c626
ToppCell	PBMC-Convalescent-Myeloid-Classical_Monocyte-Classical_Monocyte\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	IFNGR2 TFEC FCGRT FOS RAB3D	3.79e-06	198	53	5	abfef06ce9e400094de4e3fd809b09f83ad02db5
ToppCell	Healthy/Control-Classical_Monocyte\|Healthy/Control / Disease group and Cell class	IFNGR2 TFEC FCGRT FOS RAB3D	3.89e-06	199	53	5	4e8c7445d32fd2b7a50524dcd52141e76850c3df
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW16-Mesenchymal\|GW16 / Sample Type, Dataset, Time_group, and Cell type.	TFEC SAMD9 FCGRT GPR75 ADAM28	3.98e-06	200	53	5	fe22f7c97f4e37dfa7881d0f1d9245c1237d873b
ToppCell	COVID-19-COVID-19_Convalescent-Myeloid-CD14+_Monocyte\|COVID-19_Convalescent / Disease, condition lineage and cell class	IFNGR2 TFEC FCGRT FOS RAB3D	3.98e-06	200	53	5	d713c603ee103a9eabdf1bd542765c7cbf225260
ToppCell	TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_Mucinous-1\|TCGA-Stomach / Sample_Type by Project: Shred V9	CLEC20A STYXL2 RAB3A ADSS1	1.23e-05	119	53	4	5d5fcddb5723e7a94bfcf56e165a980fa450b789
ToppCell	healthy_donor-Lymphocytic-T_cell-CD4+_T_cell_(ISG_high)\|healthy_donor / Disease condition, Lineage, Cell class and subclass	SAMD9 C6 RNF43 MEOX1	2.21e-05	138	53	4	97f5dc17522462133e582b508ad0ef036e656872
ToppCell	10x5'-Lung-Lymphocytic_T_CD4-T_CD4/CD8\|Lung / Manually curated celltypes from each tissue	CFAP47 PARP8 C6 SDK1	3.57e-05	156	53	4	10d191e29b16cae8238e8df6c0ff38882253f34e
ToppCell	Posterior_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Syt6-Excitatory_Neuron.Slc17a7.Syt6-Nefm_(Layer_6a)-\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	CLEC4G CHRNG TG	3.88e-05	55	53	3	b0d37faccc8d04433ee0e76cbce2410530c4c8a1
ToppCell	Posterior_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Syt6-Excitatory_Neuron.Slc17a7.Syt6-Nefm_(Layer_6a)\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	CLEC4G CHRNG TG	3.88e-05	55	53	3	c3ebea1420b68638ed465a8cd8efba860650b795
ToppCell	Control-CD4+_T_activated\|World / Disease group and Cell class	IFNGR2 FCGRT FOS RBP4	5.34e-05	173	53	4	12f8e4276b290bb388a56de4c8d8dd60415b2f63
ToppCell	TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Dedifferentiated_Liposarcoma\|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9	FCGRT CLEC4G FGD5 MYRFL	5.58e-05	175	53	4	2eca4c168dea2017ea0e383006e28abed22f32ec
ToppCell	3'-GW_trimst-1.5-SmallIntestine-Epithelial-epithelial_progenitor_cell-Proximal_progenitor\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	TFEC CUL9 DHX32 RNF43	6.23e-05	180	53	4	8d9be9cfdf98e5888654a28ab12e5e89f201af00
ToppCell	HSPCs-Neutro_prog.\|HSPCs / Lineage and Cell class	TFEC CALR RAB3D ADSS1	6.23e-05	180	53	4	328192f4678dcdc01c806362b225e770d23498d6
ToppCell	3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.5.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TFEC ATP6AP1 FCGRT RBP4	6.64e-05	183	53	4	103c4c4595d8daa677679fd2fa1e99cd398e56dd
ToppCell	droplet-Kidney-nan-24m-Lymphocytic-CD45____plasma_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RAB3D RAB3B TG ADSS1	6.64e-05	183	53	4	edb0069c66b1465dcc0bb5881417c6b17184fd74
ToppCell	10x5'-GI_small-bowel-Lymphocytic_B-Memory_B_cells\|GI_small-bowel / Manually curated celltypes from each tissue	IFNGR2 TFEC MYT1 ADAM28	7.37e-05	188	53	4	ab1384e6f71053946368502282aeebf1ba92d33e
ToppCell	HSPCs-Gran/Mono_prog.\|HSPCs / Lineage and Cell class	TFEC CALR PARP8 ADSS1	7.83e-05	191	53	4	54620502e6aea0a615b664e861e0044dd9e0ad91
ToppCell	facs-Pancreas-Endocrine\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CALR FOS RAB3A RAB3B	8.15e-05	193	53	4	15c86e20b97b6983410b36d308cddff56d141c98
ToppCell	COVID-19-Heart-Macrophage\|Heart / Disease (COVID-19 only), tissue and cell type	TFEC FCGRT PARP8 ADAM28	8.32e-05	194	53	4	f09675cd472200363c458952f00d2e41990800ee
ToppCell	356C-Myeloid-Macrophage\|356C / Donor, Lineage, Cell class and subclass (all cells)	TFEC ATP6AP1 FCGRT RBP4	8.32e-05	194	53	4	3844e6fb43ae2e0a35ea8ccc1a2e11f40b68bc67
ToppCell	10x_5'_v1-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II\|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	IFNGR2 FCGRT FOS ADAM28	8.32e-05	194	53	4	d4ca32232ff543ce2101c29af215de1ac0dfd511
ToppCell	LA-08._Macrophage\|World / Chamber and Cluster_Paper	TFEC FCGRT PARP8 ADAM28	8.32e-05	194	53	4	c1805572bcc11b1cd29083329d7b5911489fb758
ToppCell	10x5'v1-week_17-19-Myeloid_DC-DC-DC2\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	FCGRT CALR FOS ADAM28	8.32e-05	194	53	4	833c695779edc94690b08814b0dedcf00ae082cd
ToppCell	droplet-Tongue-nan-3m-Epithelial-keratinocyte\|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FOS RAB3D ENDOU DHX32	8.32e-05	194	53	4	592e8c4b73ba424a52305ac411ea9c0a2dc44467
ToppCell	10x_5'_v1-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II-Z\|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	IFNGR2 FCGRT FOS ADAM28	8.32e-05	194	53	4	4cdd59b1dbeeae1c5cec11397b0eeea917c798fe
ToppCell	Healthy-Classical_Monocyte\|World / disease group, cell group and cell class	IFNGR2 TFEC FCGRT RAB3D	8.49e-05	195	53	4	0d96f456cc84ebb2543406fb2374c6d7cedd3c4d
ToppCell	343B-Myeloid-Macrophage\|343B / Donor, Lineage, Cell class and subclass (all cells)	TFEC ATP6AP1 FCGRT RBP4	8.49e-05	195	53	4	48ba2044d2459c8b0d17bc7deca8d0195ac6a00e
ToppCell	MS-granulo1-\|MS / Condition, Cell_class and T cell subcluster	IFNGR2 FCGRT FOS CLEC4G	8.49e-05	195	53	4	eeaa2ecbcfbfb203c77261367b43ce55e786b312
ToppCell	PBMC-Control-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_2\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	IFNGR2 TFEC FCGRT RAB3D	8.49e-05	195	53	4	0110b976f98561ecd2e20ff6e7e3960a401bb7c2
ToppCell	MS-granulo1\|MS / Condition, Cell_class and T cell subcluster	IFNGR2 FCGRT FOS CLEC4G	8.49e-05	195	53	4	29688f55a6cdefbff4e818c20cb89473fbc16a59
ToppCell	PBMC-Control-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_2\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	IFNGR2 TFEC FCGRT RAB3D	8.49e-05	195	53	4	050fc59b328391d6e3ce23051764a842dcbb3144
ToppCell	Healthy-Classical_Monocyte\|Healthy / disease group, cell group and cell class	IFNGR2 TFEC FCGRT RAB3D	8.65e-05	196	53	4	27d24aa2fd4521cf7e410688ed3b11b2d9700dd2
ToppCell	VE-granulo1-\|VE / Condition, Cell_class and T cell subcluster	IFNGR2 TFEC FCGRT FOS	8.65e-05	196	53	4	ab3f2ce294c7e503d86254a195be0cf500a2c5e4
ToppCell	VE-granulo1\|VE / Condition, Cell_class and T cell subcluster	IFNGR2 TFEC FCGRT FOS	8.65e-05	196	53	4	6dbd3acb30173d7f0b7bca0a82f435f00ca85835
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22-Myeloid-Monocytic-Classical_Monocyte-Mono_c3-CD14-VCAN\|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k)	IFNGR2 TFEC FCGRT FOS	8.65e-05	196	53	4	782aa9e75ad032627d95dba763a37ae2b1f7f503
ToppCell	COVID-granulo1-\|COVID / Condition, Cell_class and T cell subcluster	IFNGR2 TFEC FCGRT RAB3D	8.83e-05	197	53	4	190392117dc6269a21983bd3e554066fd48acd5e
ToppCell	IIH-granulo1-\|IIH / Condition, Cell_class and T cell subcluster	FCGRT FOS CLEC4G RAB3D	8.83e-05	197	53	4	51be6d5652b17c70f3a33f244efc3b728ec56f5b
ToppCell	COVID-granulo1\|COVID / Condition, Cell_class and T cell subcluster	IFNGR2 TFEC FCGRT RAB3D	8.83e-05	197	53	4	4cd774d9d5a6bf7729dc6b7bcd3ddfe3f3051ada
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Monocytic-Classical_Monocyte\|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)	IFNGR2 TFEC FCGRT RAB3D	8.83e-05	197	53	4	2afc23f7394d9b40bdf06527c5e6b553e1b02dca
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Myeloid-Monocytic-Classical_Monocyte-Mono_c2-CD14-HLA-DPB1\|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k)	IFNGR2 TFEC FCGRT FOS	8.83e-05	197	53	4	321ccd20b0bb03c99a00452ac3c637ee3aa73ecf
ToppCell	IIH-granulo1\|IIH / Condition, Cell_class and T cell subcluster	FCGRT FOS CLEC4G RAB3D	8.83e-05	197	53	4	39637e8b726bc58c0a6885c49713111f97aff881
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Myeloid-Monocytic-Classical_Monocyte-Mono_c3-CD14-VCAN\|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k)	IFNGR2 TFEC FCGRT FOS	8.83e-05	197	53	4	928d70af7b990300be69a4debce6e66b556e5d9f
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Myeloid-Monocytic-Classical_Monocyte\|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k)	IFNGR2 TFEC FCGRT FOS	8.83e-05	197	53	4	0050da0d809075fde3a7f17894dbb410b254988c
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Monocytic-Classical_Monocyte-Mono_c3-CD14-VCAN\|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)	IFNGR2 TFEC FCGRT RAB3D	8.83e-05	197	53	4	15bcfe6105c0b508811fb9bba0bc4312fea04f4c
ToppCell	3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.0.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TFEC ATP6AP1 FCGRT RBP4	8.83e-05	197	53	4	2e622d75fb45cfa80f78e1880ad056a50709895a
ToppCell	367C-Myeloid-Macrophage\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	ATP6AP1 FCGRT CALR RBP4	8.83e-05	197	53	4	f5c21f0d363b5c298a2b82f6dff4f369397b5f25
ToppCell	LAM-Myeloid-Macrophage\|Myeloid / Condition, Lineage and Cell class	ATP6AP1 FCGRT CALR RBP4	8.83e-05	197	53	4	355fe286609df2ded973952f1856bbc5f437cfd0
ToppCell	(00)_Monocyte\|World / immune cells in Peripheral Blood (logTPM normalization)	IFNGR2 FCGRT FOS RAB3D	9.00e-05	198	53	4	2252e756a8a25d32c16a723e833c1390a772c2a4
ToppCell	VE-mono1-\|VE / Condition, Cell_class and T cell subcluster	IFNGR2 TFEC FCGRT FOS	9.00e-05	198	53	4	2959d6e4992c36040ec9637f5a2daed02b35cf30
ToppCell	remission-Classical_Monocyte\|remission / disease stage, cell group and cell class	IFNGR2 TFEC FCGRT FOS	9.00e-05	198	53	4	d620ea1ee4e1b47a71059695df6c2b4793236ebc
ToppCell	PBMC-Convalescent-Myeloid\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	IFNGR2 TFEC FCGRT FOS	9.00e-05	198	53	4	3973bbc1bfb5b08dd1becd5e4bb5899b15df9e55
ToppCell	VE-mono1\|VE / Condition, Cell_class and T cell subcluster	IFNGR2 TFEC FCGRT FOS	9.00e-05	198	53	4	c742871b8ec4720b1848991551c7c1f4000ebd85
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Myeloid-Monocytic\|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k)	IFNGR2 TFEC FCGRT FOS	9.00e-05	198	53	4	4d70995b4dd6365b0c3cda3663a82efdb4870d19
ToppCell	ICU-NoSEP-Myeloid-CD14_Mono\|ICU-NoSEP / Disease, Lineage and Cell Type	TFEC FCGRT FOS RAB3D	9.00e-05	198	53	4	c7880cc998f9d8473367ea00b77d930776392ced
ToppCell	PBMC-Control-Myeloid-Classical_Monocyte\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	IFNGR2 TFEC FCGRT RAB3D	9.00e-05	198	53	4	d3c1ffb8f40d4f14b3dc9dd08c7cd73376bf9f65
ToppCell	PBMC-Control-Myeloid-Classical_Monocyte-Classical_Monocyte\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	IFNGR2 TFEC FCGRT RAB3D	9.00e-05	198	53	4	7ee8a3ea7ece300fcb8523561770a792a6c3ebd8
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Myeloid\|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k)	IFNGR2 TFEC FCGRT FOS	9.00e-05	198	53	4	2a361af16bf6ecec12f22bdf7926afc7e5ad45ae
ToppCell	COVID-19_Convalescent-Myeloid\|COVID-19_Convalescent / Disease group, lineage and cell class	IFNGR2 TFEC FCGRT FOS	9.00e-05	198	53	4	20016bfa7e651f3d22d6148469737b50369c149b
ToppCell	3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TFEC ATP6AP1 FCGRT RBP4	9.00e-05	198	53	4	1774dd36315a04c4cdcef2cc674204e4ab9c175b
ToppCell	Control-Myeloid-Classical_Monocyte\|Control / Disease group, lineage and cell class	IFNGR2 TFEC FCGRT RAB3D	9.00e-05	198	53	4	2b361d531c16e7a2d4cf676abb4421035d9bfe6e
ToppCell	Multiple_Sclerosis-Myeloid-CD14_Mono\|Multiple_Sclerosis / Disease, Lineage and Cell Type	IFNGR2 FCGRT FOS RAB3D	9.00e-05	198	53	4	128969698b2b0468cf5374f695e2d9fd02227d13
ToppCell	remission-Classical_Monocyte\|World / disease stage, cell group and cell class	IFNGR2 TFEC FCGRT FOS	9.00e-05	198	53	4	056b8745e753b1a500cf58d09a2ebf38707e1357
ToppCell	PBMC-Control-Myeloid-Classical_Monocyte\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	IFNGR2 TFEC FCGRT RAB3D	9.00e-05	198	53	4	9411067b96eca5e6f1a241f3e9419f78d0448214
ToppCell	PBMC-Control-Myeloid-Classical_Monocyte-Classical_Monocyte\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	IFNGR2 TFEC FCGRT RAB3D	9.00e-05	198	53	4	f7182ab009e8119268d1be5d3ccff516af8732e8
ToppCell	Control-Myeloid-CD14_Mono\|Control / Disease, Lineage and Cell Type	IFNGR2 FCGRT FOS RAB3D	9.00e-05	198	53	4	c8d88671d47b87a101749b3f4ab90a28f9b6bc72
ToppCell	3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TFEC ATP6AP1 FCGRT RBP4	9.00e-05	198	53	4	768df928a3265dbe7cce2acea07b2f6d6b709642
ToppCell	PBMC-Convalescent-Myeloid\|Convalescent / Location, Disease Group, Cell group, Cell class (2021.03.09)	IFNGR2 TFEC FCGRT FOS	9.00e-05	198	53	4	7e348a21c0ad6e15b4d2a58810428ab28ff8ff47
ToppCell	3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TFEC ATP6AP1 FCGRT RBP4	9.18e-05	199	53	4	5363c6df26f595f218933e38c9f628b22c6f9edd
ToppCell	3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_CCL3+-Alveolar_macrophage_CCL3+_L.1.0.2.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IFNGR2 TFEC FCGRT RBP4	9.18e-05	199	53	4	8fcb32eee0ec0dd88209e723a6f82f425c73ca40
ToppCell	COVID-19-lung-Inflammatory_monocytes_CD14hiCD16hi\|lung / Disease (COVID-19 only), tissue and cell type	TFEC ATP6AP1 FCGRT CALR	9.18e-05	199	53	4	a11957426da26a3d4f293a2b1c514d489686f496
ToppCell	PBMC-Mild-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_2\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	IFNGR2 FCGRT FOS RAB3D	9.18e-05	199	53	4	96dfbcf5261286f17d9718b04ebb7b288d229b52
ToppCell	Healthy_donor-Classical_Monocyte\|Healthy_donor / disease group, cell group and cell class (v2)	IFNGR2 FCGRT FOS RAB3D	9.18e-05	199	53	4	af3a80dbf5e0306b80f420fd41f1aaed81fe9c46
ToppCell	5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IFNGR2 TFEC FCGRT FOS	9.18e-05	199	53	4	81b3cb41abbee9785041170d0469edc50b622d7e
ToppCell	PBMC-Mild-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_2\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	IFNGR2 FCGRT FOS RAB3D	9.18e-05	199	53	4	87d513a521dd0359f4f79b01e9e97eacb0a3c6e2
ToppCell	5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.0.1.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IFNGR2 TFEC FCGRT FOS	9.18e-05	199	53	4	53dac0455b84597460457ed429969a42ed0fe932
ToppCell	5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IFNGR2 TFEC FCGRT FOS	9.18e-05	199	53	4	3216fdaba8be8e8e715aceb2c29f1ad5cc02f8ae
ToppCell	Parenchymal-10x5prime-Immune_Myeloid-Macrophage_alveolar-Macro_alveolar\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	TFEC ATP6AP1 FCGRT RBP4	9.36e-05	200	53	4	980cb0390586d8312890e8d0f3cf58e3309d16c5
ToppCell	MS-Multiple_Sclerosis-Myeloid-CD14+_Monocyte\|Multiple_Sclerosis / Disease, condition lineage and cell class	IFNGR2 FCGRT FOS RAB3D	9.36e-05	200	53	4	172244415387e35747573c1b0a89b7e6fa7d1942
ToppCell	Severe-Myeloid\|Severe / Condition, Lineage, Cell class and cell subclass	IFNGR2 TFEC FCGRT FOS	9.36e-05	200	53	4	77ae7b037226d479b37077d20a3cc150da251900
ToppCell	BAL-Severe-Myeloid\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	IFNGR2 TFEC FCGRT FOS	9.36e-05	200	53	4	bb246c630b2fde1633b28838a5f087fdfb4bc4a5
ToppCell	Control-Control-Myeloid-CD14+_Monocyte\|Control / Disease, condition lineage and cell class	IFNGR2 TFEC FCGRT RAB3D	9.36e-05	200	53	4	97fb2599b353ef9899cd391122a189f1583fa4a6
ToppCell	COVID-19-Myeloid\|COVID-19 / Condition, Lineage and Cell class	IFNGR2 TFEC FCGRT FOS	9.36e-05	200	53	4	4c9e936b5e100c1a3ef10ea262febccf8226df9f
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW19-Neuroepithelial-Proteoglycan-expressing_cell\|GW19 / Sample Type, Dataset, Time_group, and Cell type.	TFEC SAMD9 FCGRT ADAM28	9.36e-05	200	53	4	aafe594c88710f8c53d59667cdac5035e08f5511
ToppCell	BAL-Severe-Myeloid-MoAM\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	IFNGR2 TFEC FCGRT FOS	9.36e-05	200	53	4	43ec6732cc255d533170ebf95d282e503606dcc6
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW16-Mesenchymal-BMP_responsible_cell\|GW16 / Sample Type, Dataset, Time_group, and Cell type.	TFEC SAMD9 FCGRT ADAM28	9.36e-05	200	53	4	26251ed8c7fa7e87973d6f59bd398c88ad025395
ToppCell	Parenchymal-10x5prime-Immune_Myeloid-Macrophage_alveolar\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	TFEC ATP6AP1 FCGRT RBP4	9.36e-05	200	53	4	d7d971586c01152b3d21956fd98280588cb8f08b
Drug	Phenylthiourea	FOS RBP4 TG	4.26e-06	14	53	3	ctd:D010670
Disease	lung adenocarcinoma (is_implicated_in)	CALR RNF43 ADAM28 CHRNA5	1.46e-06	49	50	4	DOID:3910 (is_implicated_in)
Disease	level of meprin A subunit beta in blood serum	TRAPPC8 RNF138	1.68e-05	4	50	2	OBA_2044983
Disease	Anxiety States, Neurotic	FOS CHRNA5 TG	5.77e-05	44	50	3	C0376280
Disease	Anxiety Disorders	FOS CHRNA5 TG	5.77e-05	44	50	3	C0003469
Disease	Anxiety neurosis (finding)	FOS CHRNA5 TG	5.77e-05	44	50	3	C1279420
Disease	gallbladder cancer (is_marker_for)	CALR RBP4	5.88e-05	7	50	2	DOID:3121 (is_marker_for)
Disease	tea consumption measurement	MYT1 PEX7 CUL9 PCMTD2	6.87e-05	129	50	4	EFO_0010091
Disease	complement component C6 measurement	PARP8 C6	2.17e-04	13	50	2	EFO_0020281
Disease	alcohol use disorder (implicated_via_orthology)	RAB3D RAB3A RAB3B CHRNG	3.36e-04	195	50	4	DOID:1574 (implicated_via_orthology)
Disease	cytotoxicity measurement, response to clozapine	MYT1 PCMTD2	1.11e-03	29	50	2	EFO_0006952, GO_0097338

Protein segments in the cluster

Peptide	Gene	Start	Entry
ALSFYIPTDFSSCSR	ADAM28	366	Q9UKQ2
FRSACSISVTYFPFD	CHRNG	146	P07510
VVSACSLETYAFPFD	HTR3B	151	O95264
SSGKFFCLYTEEFAS	DHX32	396	Q7L7V1
TSFLFRYADDSFTPA	RAB3A	36	P20336
TSFLFRYADDTFTPA	RAB3B	36	P20337
TSFLFRYADDSFTPA	RAB3D	36	O95716
FLATATAAYPDFSAS	MEOX1	51	P50221
FTSDPALLSFAEYFC	ANAPC1	1741	Q9H1A4
DCLFADFRYSDSTFT	PARP8	26	Q8N3A8
FVFTYPEADSFPSCA	FOS	341	P01100
FSVLTCSAFSFYPPE	FCGRT	216	P55899
TSDSFDKFDFCEPSF	PCMTD2	131	Q9NV79
SPFHASVLASCSYDF	PEX7	251	O00628
PDGSLCSFATTDDFY	MYOD1	16	P15172
CSFATTDDFYDDPCF	MYOD1	21	P15172
GSSPEFEFALYSLCF	ENDOU	351	P21128
PYEFFPTESTSFCSE	FGD5	346	Q6ZNL6
SFFFLEPYRSSSCTS	MEGF8	836	Q7Z7M0
DCSTDPYFAGIFFTD	MYRFL	886	Q96LU7
APETSSSACFAQEFF	OR51A2	91	Q8NGJ7
FFSSASSIPDAFCFT	GPR75	106	O95800
TSDLSIFCFYSRAFE	NCKAP1	536	Q9Y2A7
FFGTSFCVDFSSPST	OR1G1	251	P47890
YKSSCTIDVTFFPFD	CHRNA5	166	P30532
CVFDTDSNDYFTSPA	C6	801	P13671
DSNDYFTSPACKFLA	C6	806	P13671
EADSAFSLLATCSFY	DPH7	426	Q9BTV6
DARFYALSASFEPFS	CALR	71	P27797
SPFDIADTSTAFFCY	IFNGR2	161	P38484
FSCFYSPASQSEDVI	KCNMB3	186	Q9NPA1
PTEFCDALDRFSSFY	CUL9	1721	Q8IWT3
FTAYFTSVLCFTTPG	SDK1	941	Q7Z5N4
DSFIYESSAFRFSSP	CFAP47	2796	Q6ZTR5
CQENPSAFSSFDFSY	MEIOC	536	A2RUB1
FTFYPCVLATEGFTS	TRIM39	376	Q9HCM9
DIDFGTYPFVTSSNC	ADSS1	261	Q8N142
SIDLTCVSYPFDEFS	SAMD9	156	Q5K651
SAATSYTEDDFYCPV	RNF138	6	Q8WVD3
TFCSSLSSDFDPLVY	RNF43	496	Q68DV7
SFEGSCYFFSVPKTT	CLEC4G	171	Q6UXB4
CSSLLPFFCFYDSST	CLEC20A	266	Q6ZU45
PFFCFYDSSTGHRAS	CLEC20A	271	Q6ZU45
YDFTSSEDAPCAVTF	WDR90	736	Q96KV7
TCADSYSFVFSRDPN	RBP4	146	P02753
DSVGSEASSFYNFCS	STYXL2	521	Q5VZP5
SFSSFDTTDEGPVYC	SCARF2	551	Q96GP6
QFSYASDCASFFSPG	ATP6AP1	411	Q15904
DLASVYCFLTVFSPF	PIGN	811	O95427
AAFSSFLPESTACPY	PROP1	141	O75360
GPYTFSICDTSNFSD	UBA1	271	P22314
FFPDEYFTCSSLCLS	ZFYVE1	421	Q9HBF4
LPFSTVYLCDAAFSA	ZMYM6	1276	O95789
EQIISSASPCADFFY	TRAPPC8	1186	Q9Y2L5
SASPCADFFYRSLSS	TRAPPC8	1191	Q9Y2L5
CDQAIAFSDPLSYFT	TFEC	276	O14948
AFSDPLSYFTDLSFS	TFEC	281	O14948
FTVSTTEPEISCDFY	TG	1616	P01266
TSETSPKAFQCFDYS	MYT1	606	Q01538